GB Patent

GB2483579A — Sublingual formulations comprising methadone and ethanol for use in reducing pain

Assigned to LondonPharma Ltd · Expires 2012-03-14 · 14y expired

What this patent protects

A pharmaceutical formulation comprises methadone and ethanol for use in reducing pain wherein the composition is delivered sublingually. Preferably, the composition is comprised within a container formed from cyclic olefin copolymer (COC). Preferably, the container further includ…

USPTO Abstract

A pharmaceutical formulation comprises methadone and ethanol for use in reducing pain wherein the composition is delivered sublingually. Preferably, the composition is comprised within a container formed from cyclic olefin copolymer (COC). Preferably, the container further includes a delivery device to dispense the composition in a single discharge as a spray. Preferably, the delivery device is non-pressurised and comprises seals and/or plungers being formed from bromobutyl polymer.

Drugs covered by this patent

Patent Metadata

Patent number
GB2483579A
Jurisdiction
GB
Classification
—
Expires
2012-03-14
Drug substance claim
No
Drug product claim
No
Assignee
LondonPharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.